Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 25.50
0.00 (0.00%)
Nov 11, 2026, 4:08 PM HKT
HKG:3378 Market Cap
HKG:3378 has a market cap or net worth of 3.47 billion as of November 10, 2026. It is the 15,238th most valuable company in the world and the 680th biggest in Hong Kong.
Market Cap
3.47B
Enterprise Value
2.99B
Revenue
84.28K
Global Rank
Country Rank
#680 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2025, HKG:3378's market cap has increased from 2.34B to 3.47B, an increase of 48.26%. That is a compound annual growth rate of 56.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.47B | 59.57% |
| Dec 31, 2025 | 2.18B | -7.09% |
| Dec 23, 2025 | 2.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbisko Medicine | 4.29B |
| Frontage Holdings | 4.25B |
| Ocumension Therapeutics | 4.06B |
| TenNor Therapeutics (Suzhou) | 3.75B |
| Jacobio Pharmaceuticals Group | 3.69B |
| Mirxes Holding Company | 3.66B |
| TransThera Sciences (Nanjing) | 3.31B |
| Qyuns Therapeutics | 3.26B |